T1	Participants 0 92	Prevention of regimen-related toxicities after bone marrow transplantation by pentoxifylline
T2	Participants 521 544	patients undergoing BMT
T3	Participants 611 689	140 patients undergoing either allogeneic (n = 51) or autologous BMT (n = 89).
